Xeris Biopharma Holdings Inc (XERS)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Paul R. Edick
Employees:
290
180 N. LASALLE STREET, SUITE 1600, CHICAGO, IL, 60601
844-445-5704

Xeris Biopharma Holdings, Inc. engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; Keveyis, a therapy for the. treatment of hyperkalemic, hypokalemic. and related variants of primary periodic paralysis.

Data derived from most recent annual or quarterly report
Market Cap 93.1 Million Shares Outstanding66.5 Million Avg 30-day Volume 630.064 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue2.1596 Debt to Equity2.5165 EBITDA-110.04 Million
Price to Book Value3.8533 Operating Margin-117.14489999999999 Enterprise Value257.159 Million
Current Ratio2.172 EPS Growth0 Quick Ratio1.764
1 Yr BETA 1.2531 52-week High/Low 3.17 / 1.19 Profit Margin-134.9436
Operating Cash Flow Growth-49.3945 Altman Z-Score-2.6728 Free Cash Flow to Firm 0
View SEC Filings from XERS instead.

View recent insider trading info

Funds Holding XERS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding XERS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2021-10-05:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-10-05:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-09-14:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-07-30:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-07-29:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-07-19:
    Item 8.01: Other Events
  • 8-K: filed on 2021-06-08:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2021-05-24:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-05-13:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SHERMAN JEFFREY W

    • Director
    90,378 2022-06-08 1

    PERSKY MARLA

    • Director
    40,000 2022-06-08 1

    JOHNSON JOHN

    • Director
    518,312 2022-06-08 1

    KONG GARHENG

    • Director
    90,170 2022-06-08 1

    SCHMID JOHN P.

    • Director
    45,659 2022-06-08 1

    BORMANN-KENNEDY BARBARA-JEAN ANNE

    • Director
    40,000 2022-06-08 1

    HALKUFF DAWN

    • Director
    40,000 2022-06-08 1

    EDICK PAUL R SEE REMARKS

    • Officer
    • Director
    1,541,494 2022-05-12 2

    PRESTRELSKI STEVEN CHIEF SCIENTIFIC OFFICER

    • Officer
    569,780 2022-02-22 2

    SHANNON JOHN PATRICK JR SEE REMARKS

    • Officer
    618,910 2022-01-03 1

    HECHT BETH SEE REMARKS

    • Officer
    436,821 2022-01-03 1

    JOHNSON KENNETH ERLAND SEE REMARKS

    • Officer
    165,865 2022-01-03 1

    PIEPER STEVEN SEE REMARKS

    • Officer
    388,834 2022-01-03 1

    DEUTSCH BARRY M. SEE REMARKS

    • Officer
    208,090 2021-01-29 0

    THIERER MARK

    • Director
    0 2020-06-04 0

    RIGBY JONATHAN

    • Director
    0 2019-02-27 0

    REDMILE GROUP, LLC

    GREEN JEREMY

    • 10% Owner
    3,000,642 2019-02-19 0

    FLYNN JAMES E

    DEERFIELD MGMT L.P.

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    DEERFIELD SPECIAL SITUATIONS FUND, L.P.

    DEERFIELD MGMT III, L.P.

    DEERFIELD PRIVATE DESIGN FUND III, L.P.

    • 10% Owner
    • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
    2,355,136 2019-02-08 0

    FLYNN JAMES E

    FLYNN JAMES E

    DEERFIELD MGMT L.P.

    DEERFIELD MGMT L.P.

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

    DEERFIELD SPECIAL SITUATIONS FUND, L.P.

    DEERFIELD SPECIAL SITUATIONS FUND, L.P.

    DEERFIELD MGMT III, L.P.

    DEERFIELD MGMT III, L.P.

    DEERFIELD PRIVATE DESIGN FUND III, L.P.

    DEERFIELD PRIVATE DESIGN FUND III, L.P.

    • 10% Owner
    • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
    4,972,728 2019-02-05 0

    PALMETTO PARTNERS, LTD.

    PALMETTO PARTNERS 2014, LP

    PALMETTO PARTNERS 2015, LP

    • 10% Owner
    0 2018-06-25 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    XERIS BIOPHARMA HOLDINGS INC XERS 2022-11-25 22:15:03 UTC 1.5399 2.2801 1400000
    XERIS BIOPHARMA HOLDINGS INC XERS 2022-11-25 21:45:04 UTC 1.5442 2.2758 1400000
    XERIS BIOPHARMA HOLDINGS INC XERS 2022-11-25 21:15:03 UTC 1.5442 2.2758 1400000
    XERIS BIOPHARMA HOLDINGS INC XERS 2022-11-25 20:45:03 UTC 1.5527 2.2673 1400000
    XERIS BIOPHARMA HOLDINGS INC XERS 2022-11-25 20:15:03 UTC 1.5527 2.2673 1400000
    XERIS BIOPHARMA HOLDINGS INC XERS 2022-11-25 19:45:04 UTC 1.5527 2.2673 1400000
    XERIS BIOPHARMA HOLDINGS INC XERS 2022-11-25 19:15:03 UTC 1.5527 2.2673 1400000
    XERIS BIOPHARMA HOLDINGS INC XERS 2022-11-25 18:45:03 UTC 1.5237 2.2963 1400000
    XERIS BIOPHARMA HOLDINGS INC XERS 2022-11-25 18:15:03 UTC 1.5237 2.2963 1400000
    XERIS BIOPHARMA HOLDINGS INC XERS 2022-11-25 17:45:04 UTC 1.5237 2.2963 1400000
    XERIS BIOPHARMA HOLDINGS INC XERS 2022-11-25 17:15:03 UTC 1.5237 2.2963 1400000
    XERIS BIOPHARMA HOLDINGS INC XERS 2022-11-25 16:45:04 UTC 1.5616 2.2584 1400000
    XERIS BIOPHARMA HOLDINGS INC XERS 2022-11-25 16:15:03 UTC 1.5616 2.2584 1400000
    XERIS BIOPHARMA HOLDINGS INC XERS 2022-11-25 15:45:03 UTC 1.5616 2.2584 1400000
    XERIS BIOPHARMA HOLDINGS INC XERS 2022-11-25 15:15:03 UTC 1.5616 2.2584 1400000
    XERIS BIOPHARMA HOLDINGS INC XERS 2022-11-25 14:45:04 UTC 1.5616 2.2584 1400000
    XERIS BIOPHARMA HOLDINGS INC XERS 2022-11-25 14:15:04 UTC 1.5616 2.2584 1400000
    XERIS BIOPHARMA HOLDINGS INC XERS 2022-11-25 13:45:03 UTC 1.6149 2.2051 1400000
    XERIS BIOPHARMA HOLDINGS INC XERS 2022-11-25 13:15:03 UTC 1.6149 2.2051 1400000
    XERIS BIOPHARMA HOLDINGS INC XERS 2022-11-25 12:45:03 UTC 1.6149 2.2051 1400000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    AQR Funds- AQR Small Cap Relaxed Constraint Equity Fund XERS -1006.0 shares, $-9888.98 2019-09-30 N-PORT
    RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund XERS -23815.0 shares, $-33817.3 2022-07-31 N-PORT
    RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund XERS -4900.0 shares, $-7644.0 2022-09-30 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund XERS -17142.0 shares, $-26741.52 2022-09-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments